Değer202020212022202320242025TTMSatış/genel/idari giderler14.2 B14.89 B14.25 B12.52 B12.57 B13.25 B—Araştırma ve geliştirme8.98 B9.54 B10 B11.37 B10.02 B11.2 B—Faaliyet karı10.15 B11.69 B9.2 B9.77 B14.54 B17.64 B—Faaliyet Dışı Gelir, Toplam———————Faiz gideri (aktifleştirilmiş faizler düşüldükten sonra)———————Faaliyet Dışı Gelir (Faiz Giderleri Hariç)———————Olağandışı gelirler/giderler———————Vergi öncesi kar9.88 B26.14 B2.38 B596 M3.54 B329 M—Kazançlardaki özsermayeler———————Vergiler1.81 B2.12 B1.42 B551 M1.7 B2.38 B—Kontrol gücü olmayan/azınlık payı1 M3 M04 M2 M17 M—Vergi sonrası diğer gelirler/giderler———————Durdurulan faaliyetler öncesi net kar3.48 B19.43 B6.96 B8.57 B5.66 B7.68 B—Durdurulan faaliyetler4.59 B4.59 B—6.28 B6.28 B6.28 B—Net kar8.07 B24.02 B6.96 B14.85 B11.94 B13.97 B—Seyreltme ayarlaması———————İmtiyazlı temettüler———————Adi hisse senedi sahiplerine düşen seyreltilmiş net kar———————Temel hisse başına kazanç (Temel EPS)———————Seyreltilmiş hisse başına kazanç (Seyreltilmiş EPS)———————Dolaşımdaki ortalama adi hisse senedi sayısı———————Dolaşımdaki seyreltilmiş hisse senedi sayısı———————FAVÖK———————FVÖK———————Gelir maliyeti15.12 B15.87 B15.49 B12.47 B12.83 B13.7 B—Satılan malların diğer maliyeti———————Amortisman ve itfa (nakit akışı)———————
Novartis AG
Novartis AG is a Swiss multinational pharmaceutical corporation based in Basel, Switzerland. Novartis is one of the largest pharmaceutical companies in the world and was the eighth largest by revenue in 2024.
Novartis manufactures the drugs clozapine, diclofenac, carbamazepine, valsartan, imatinib mesylate, cyclosporine, letrozole, methylphenidate, terbinafine, deferasirox, and others.
Novartis was formed in 1996 by the merger of Ciba-Geigy and Sandoz. It was considered the largest corporate merger in history during that time. The pharmaceutical and agrochemical divisions of both companies formed Novartis as an independent entity. The name Novartis was based on the Latin terms, novae artes.
After the merger, other Ciba-Geigy and Sandoz businesses were sold, or, like Ciba Specialty Chemicals, spun off as independent companies. The Sandoz brand disappeared for three years, but was revived in 2003 when Novartis consolidated its generic drugs businesses into a single subsidiary and named it Sandoz.